The effects of metabolic alterations on teratogenesis.
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000086:Acetazolamide / Q000009:adverse effects; D000138:Acidosis / Q000150:complications*; D000142:Acidosis, Respiratory; D000496:Alloxan / Q000009:adverse effects; D000818:Animals; D001724:Birth Weight; D001786:Blood Glucose / Q000032:analysis; D002257:Carbonic Anhydrase Inhibitors; D000013:Congenital Abnormalities / Q000209:etiology*; D005260:Female; D005313:Fetal Death / Q000209:etiology; D005333:Fetus / Q000032:analysis; D005951:Glucose Tolerance Test; D007008:Hypokalemia / Q000139:chemically induced / Q000150:complications; D007328:Insulin / Q000009:adverse effects; D011188:Potassium / Q000032:analysis; D011191:Potassium Deficiency / Q000150:complications*; D011247:Pregnancy; D011248:Pregnancy Complications; D051381:Rats; D012272:Ribs / Q000002:abnormalities
D001786:Blood Glucose; D002257:Carbonic Anhydrase Inhibitors; D007328:Insulin; D000496:Alloxan; D000086:Acetazolamide; D011188:Potassium